Céline M Laumont

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Transcription Factor

Endothelial Cells

Top Venues

Science advances

Nature reviews. Cancer

Biochemistry and cell biology = Biochimie et biologie cellulaire

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton, Monica Alvaro Fuss, Shreena Kalaria, Céline M Laumont, Julian Smazynski, Monica Mesa, Allyson C Banville, Xinpei Jiang, Russell William Jenkins, Israel Cañadas, Brad H Nelson
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma. Science advances 10 (20) (2024)
Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton, Monica Alvaro Fuss, Shreena Kalaria, Céline M Laumont, Julian Smazynski, Monica Mesa, Allyson C Banville, Xinpei Jiang, Russell William Jenkins, Israel Cañadas, Brad H Nelson
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma. Science advances 10 (20) (2024)
Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton, Monica Alvaro Fuss, Shreena Kalaria, Céline M Laumont, Julian Smazynski, Monica Mesa, Allyson C Banville, Xinpei Jiang, Russell William Jenkins, Israel Cañadas, Brad H Nelson
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma. Science advances 10 (20) (2024)
Stacey N Lee, Victoria Hoskin, Céline M Laumont, Shannon Snelling, Lorenzo Lindo, Lou Bird, Vera Samarkina, Chantale Thurston, Grace Fox, Sarah Ivanco, Megan Mahoney, Jeanette E Boudreau, Sarah Nersesian
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings. Biochemistry and cell biology = Biochimie et biologie cellulaire (2023)
Céline M Laumont, Allyson C Banville, Mara Gilardi, Daniel P Hollern, Brad H Nelson
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nature reviews. Cancer 22 (7) (2022)
Céline M Laumont, Krystel Vincent, Leslie Hesnard, Eric Olivier Audemard, Éric Bonneil, Jean-Philippe Laverdure, Patrick Gendron, Mathieu Courcelles, Marie-Pierre Hardy, Caroline Côté, Chantal Durette, Charles St-Pierre, Mohamed Benhammadi, Joël Lanoix, Suzanne Vobecky, Elie Haddad, Sébastien Lemieux, Pierre Thibault, Claude Perreault
Noncoding regions are the main source of targetable tumor-specific antigens. Science translational medicine 10 (470) (2019)